Novel platforms for developing therapies for transformed gliomas in patients with NF1

Our team is requesting CBTN specimens to help support our efforts in the above stated aims for our project. The Children’s National Hospital Brain Tumor Biorepository currently has one NF-1 cell line which was obtained from Eric Raabe (JHU). We have developed the experience and expertise to culture cells for pre-clinical studies. The CBTN samples will greatly add to our endeavors.